The Technical Analyst
Select Language :
Navidea [NAVB]

Exchange: AMEX Industry: Biotechnology

Navidea Price, Forecast, Insider, Ratings, Fundamentals & Signals

Navidea is listed at the  Exchange

1.33% $0.0381

America/New_York / 26 apr 2024 @ 13:08



Navidea PE Comparison

Report updated: 2024-04-28 @ 13:50
Comp Ticker PE
Palatin Technologies Inc PTN -27.900
NovaBay Pharmaceuticals NBY -18.230
Actinium Pharmaceuticals ATNM -9.150
Timber Pharmaceuticals TMBR -7.810
Can-Fite Biopharma Ltd CANF -6.240
CorMedix Inc CRMD -5.880
Annovis Bio Inc ANVS -5.840
Matinas BioPharma MTNB -5.040
Lineage Cell Therapeutics LCTX -4.950
22nd Century Group Inc XXII -4.810
Ibio Inc IBIO -4.550
CEL-SCI Corp CVM -3.260
Protalix Biotherapeutics PLX -3.180
AgeX Therapeutics Inc AGE -2.950
Armata Pharmaceuticals ARMP -2.780
Ampio Pharmaceuticals Inc AMPE -2.390
NanoViricides Inc NNVC -1.880
AIM ImmunoTech Inc AIM -1.630
Cybin Inc. CYBN -1.410
Oragenics Inc OGEN -1.010
Navidea NAVB -0.690
OncoCyte Corp OCX -0.570
Biomx Inc PHGE -0.190

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.